Cargando…

DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol

By reducing their metabolism, dipeptidyl peptidase 4 inhibition (DPP4I) enhances the effects of numerous peptides including neuropeptide Y(1–36) (NPY(1–36)), peptide YY(1–36) (PYY(1–36)), and SDF-1α. Studies show that separately NPY(1–36), PYY(1–36) and SDF-1α stimulate proliferation of, and collage...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Edwin K., Gillespie, Delbert G., Tofovic, Stevan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174788/
https://www.ncbi.nlm.nih.gov/pubmed/32015161
http://dx.doi.org/10.1124/jpet.119.263467
_version_ 1783524700652044288
author Jackson, Edwin K.
Gillespie, Delbert G.
Tofovic, Stevan P.
author_facet Jackson, Edwin K.
Gillespie, Delbert G.
Tofovic, Stevan P.
author_sort Jackson, Edwin K.
collection PubMed
description By reducing their metabolism, dipeptidyl peptidase 4 inhibition (DPP4I) enhances the effects of numerous peptides including neuropeptide Y(1–36) (NPY(1–36)), peptide YY(1–36) (PYY(1–36)), and SDF-1α. Studies show that separately NPY(1–36), PYY(1–36) and SDF-1α stimulate proliferation of, and collagen production by, cardiac fibroblasts (CFs), preglomerular vascular smooth muscle cells (PGVSMCs), and glomerular mesangial cells (GMCs), particularly in cells isolated from genetically hypertensive rats. Whether certain combinations of these factors, in the absence or presence of DPP4I, are more profibrotic than others is unknown. Here we contrasted 24 different combinations of conditions (DPP4I, hypertensive genotype and physiologic levels [3 nM] of NPY(1–36), PYY(1–36), or SDF-1α) on proliferation of, and [(3)H]-proline incorporation by, CFs, PGVSMCs, and GMCs. In all three cell types, the various treatment conditions differentially increased proliferation and [(3)H]-proline incorporation, with a hypertensive genotype + DPP4I + NPY(1–36) + SDF-1α being the most efficacious combination. Although the effects of this four-way combination were similar in male versus female CFs, physiologic (1 nM) concentrations of 2-methoxyestradiol (2ME; nonestrogenic metabolite of 17β-estradiol), abolished the effects of this combination in both male and female CFs. In conclusion, this study demonstrates that CFs, PGVSMCs, and GMCs are differentially activated by various combinations of NPY(1–36), PYY(1–36), SDF-1α, a hypertensive genetic background and DPP4I. We hypothesize that as these progrowth conditions accumulate, a tipping point would be reached that manifests in the long term as organ fibrosis and that 2ME would obviate any profibrotic effects of DPP4I, even under the most profibrotic conditions (i.e., hypertensive genotype with high NPY(1–36) + SDF-1α levels and low 2ME levels). SIGNIFICANCE STATEMENT: This work elucidates combinations of factors that could contribute to long-term profibrotic effects of dipeptidyl peptidase 4 inhibitors and suggests a novel drug combination that could prevent any potential profibrotic effects of dipeptidyl peptidase 4 inhibitors while augmenting the protective effects of this class of antidiabetic agents.
format Online
Article
Text
id pubmed-7174788
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The American Society for Pharmacology and Experimental Therapeutics
record_format MEDLINE/PubMed
spelling pubmed-71747882020-05-06 DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol Jackson, Edwin K. Gillespie, Delbert G. Tofovic, Stevan P. J Pharmacol Exp Ther Cardiovascular By reducing their metabolism, dipeptidyl peptidase 4 inhibition (DPP4I) enhances the effects of numerous peptides including neuropeptide Y(1–36) (NPY(1–36)), peptide YY(1–36) (PYY(1–36)), and SDF-1α. Studies show that separately NPY(1–36), PYY(1–36) and SDF-1α stimulate proliferation of, and collagen production by, cardiac fibroblasts (CFs), preglomerular vascular smooth muscle cells (PGVSMCs), and glomerular mesangial cells (GMCs), particularly in cells isolated from genetically hypertensive rats. Whether certain combinations of these factors, in the absence or presence of DPP4I, are more profibrotic than others is unknown. Here we contrasted 24 different combinations of conditions (DPP4I, hypertensive genotype and physiologic levels [3 nM] of NPY(1–36), PYY(1–36), or SDF-1α) on proliferation of, and [(3)H]-proline incorporation by, CFs, PGVSMCs, and GMCs. In all three cell types, the various treatment conditions differentially increased proliferation and [(3)H]-proline incorporation, with a hypertensive genotype + DPP4I + NPY(1–36) + SDF-1α being the most efficacious combination. Although the effects of this four-way combination were similar in male versus female CFs, physiologic (1 nM) concentrations of 2-methoxyestradiol (2ME; nonestrogenic metabolite of 17β-estradiol), abolished the effects of this combination in both male and female CFs. In conclusion, this study demonstrates that CFs, PGVSMCs, and GMCs are differentially activated by various combinations of NPY(1–36), PYY(1–36), SDF-1α, a hypertensive genetic background and DPP4I. We hypothesize that as these progrowth conditions accumulate, a tipping point would be reached that manifests in the long term as organ fibrosis and that 2ME would obviate any profibrotic effects of DPP4I, even under the most profibrotic conditions (i.e., hypertensive genotype with high NPY(1–36) + SDF-1α levels and low 2ME levels). SIGNIFICANCE STATEMENT: This work elucidates combinations of factors that could contribute to long-term profibrotic effects of dipeptidyl peptidase 4 inhibitors and suggests a novel drug combination that could prevent any potential profibrotic effects of dipeptidyl peptidase 4 inhibitors while augmenting the protective effects of this class of antidiabetic agents. The American Society for Pharmacology and Experimental Therapeutics 2020-04 2020-04 /pmc/articles/PMC7174788/ /pubmed/32015161 http://dx.doi.org/10.1124/jpet.119.263467 Text en Copyright © 2020 by The Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the CC BY-NC Attribution 4.0 International license (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular
Jackson, Edwin K.
Gillespie, Delbert G.
Tofovic, Stevan P.
DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title_full DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title_fullStr DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title_full_unstemmed DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title_short DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
title_sort dpp4 inhibition, npy(1-36), pyy(1-36), sdf-1α, and a hypertensive genetic background conspire to augment cell proliferation and collagen production: effects that are abolished by low concentrations of 2-methoxyestradiol
topic Cardiovascular
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174788/
https://www.ncbi.nlm.nih.gov/pubmed/32015161
http://dx.doi.org/10.1124/jpet.119.263467
work_keys_str_mv AT jacksonedwink dpp4inhibitionnpy136pyy136sdf1aandahypertensivegeneticbackgroundconspiretoaugmentcellproliferationandcollagenproductioneffectsthatareabolishedbylowconcentrationsof2methoxyestradiol
AT gillespiedelbertg dpp4inhibitionnpy136pyy136sdf1aandahypertensivegeneticbackgroundconspiretoaugmentcellproliferationandcollagenproductioneffectsthatareabolishedbylowconcentrationsof2methoxyestradiol
AT tofovicstevanp dpp4inhibitionnpy136pyy136sdf1aandahypertensivegeneticbackgroundconspiretoaugmentcellproliferationandcollagenproductioneffectsthatareabolishedbylowconcentrationsof2methoxyestradiol